Menstruation Clinical Trials

A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 86 clinical trials
A Study to Evaluate the Efficacy Safety and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin Hizentra) in Adults with Dermatomyositis (DM)

Subjects will be randomized to 1 of 2 treatment sequences: Sequence A: 0.5 g/kg IgPro20 for 24 weeks followed by 0.5 g/kg IgPro20 for 28 weeks or Sequence B: placebo for 24 weeks followed by 0.5 g/kg IgPro20 for 28 weeks. Screening: about 2 months, 52-week treatment period. Duration of …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Pilot Study to Evaluate the Effect of CT1812 Treatment on A-beta Oligomer Displacement into CSF in Subjects with Mild to Moderate Alzheimer's Disease

Subjects will be randomized in a 2:1 (active:placebo) ratio and admitted inpatient (CTRC) for a Confinement Visit that will take place over 2 days, consisting of four phases: admission, 24-hour CSF and plasma sampling, 6-hour period of observation, and discharge. Participants will have CSF and plasma sampling for 3 hours …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to determine the safety tolerability pharmacokinetics and pharmacodynamics of DNL201 in subjects with Parkinsons Disease

The purpose of this research is to investigate whether DNL201 (the study drug) is safe and tolerable in Parkinson’s disease patients and to investigate how DNL201 is absorbed, broken down, and eliminated from the body. ™ 

  • 0 views
  • 19 Feb, 2024
  • 1 location
TRaCkLIGHT study for people with moderate to severe Crohn's Disease

Patients with moderate to severe Crohn's disease, who have failed prior treatment with the standard anti-TNF therapy will receive the study medication - MDGN-002 - which may help treat the Crohn's disease and relieve its symptoms.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Research Study of a Levonorgestrel 52 MG IUD for the treatment of heavy menstrual bleeding

Healthy women 18 to 50 years of age who are seeking treatment for heavy menstrual bleeding and do not wish to become pregnant during the next ten months are invited to participate.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A DOUBLE BLIND RANDOMIZED VEHICLE CONTROLLED CROSSOVER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOPICAL NALOXONE HYDROCHLORIDE LOTION 0.5% FOR THE RELIEF OF PRURITUS IN PATIENTS WITH THE MYCOSIS FUNGOIDES (MF) FORM OF CUTANEOUS T-CELL LYMPHOMA (CTCL

The crossover treatment design entails an initial randomized assignment to either Naloxone Lotion or the Vehicle Lotion for a two-week period, and after a suitable washout period, an assignment to the alternative treatment for a second two-week period. Study participation involves four periods: a) Screening Period, b) Treatment Period 1, …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Prospective Randomized Double-Blind Placebo-Controlled Crossover Study to Evaluate the Clinical Utility of the Vascular Health Profile Diagnostics Assay (VHP) in Assessment of Response to Administration of a HMG-CoA reductase inhibitor (statin) as Primary Prevention in Patients with Asymptomatic Atherosclerosis

The two treatment periods will be separated by a four-week washout period. During the first period one of the sequence of subjects will receive drug and the other will receive placebo.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Evaluate the Effects of Annovera and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

Normal 0 false false false EN-US X-NONE X-NONE This study involves research about Annovera, an FDA-approved contraceptive vaginal system. The Annovera vaginal system is a ring made of a silicone rubber, which is inserted into your vagina. Annovera contains 2 hormones. One is a progestin called segesterone acetate (SA) and …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Randomized Controlled Trial of Home Therapy with Caffeine Citrate in Moderately Preterm Infants with Apnea of Prematurity

The primary outcome of the study will be the number of days of hospitalization from randomization to discharge up to 48 weeks post-menstrual age (PMA), with censoring at time of transfer or death. The eligibility criteria for the study are inborn and outborn infants of 29 0/7 to 33 6/7 …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Randomized Controlled Trial of Women Involved in Supporting Health (WISH), a Peer-Led Intervention to Improve Postpartum Retention in HIV Care

The purpose of the study is to learn more about programs that can improve the health and wellbeing of mothers and their babies during the period after delivery. Women living with HIV experience diverse health problems in the period directly after delivery. These problems are related to poor medical visit …

  • 0 views
  • 19 Feb, 2024